Cost of illness and program of dengue: A systematic review

Oliveira, Luana Nice da Silva; Itria, Alexander; Lima, Erika Coutinho

doi:10.1371/journal.pone.0211401

Cited by 37 publications

(44 citation statements)

References 44 publications

(86 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Data from Australia, one of the few high income countries with dengue transmission which utilises active surveillance, has shown that rapid notification and case finding enables the minimisation of transmission by triggering public health responses [44]. However, active surveillance systems are expensive and implementation would require a robust cost-benefit analysis [45].…”

Section: Plos Neglected Tropical Diseasesmentioning

confidence: 99%

Epidemiology of dengue fever in Guatemala

Signor¹,

Edwards²,

Escobar³

et al. 2020

PLoS Negl Trop Dis

View full text Add to dashboard Cite

Dengue fever occurs worldwide and about 1% of cases progress to severe haemorrhage and shock. Dengue is endemic in Guatemala and its surveillance system could document long term trends. We analysed 17 years of country-wide dengue surveillance data in Guatemala to describe epidemiological trends from 2000 to 2016.Data from the national dengue surveillance database were analysed to describe dengue serotype frequency, seasonality, and outbreaks. We used Poisson regression models to compare the number of cases each year with subsequent years and to estimate incidence ratios within serotype adjusted by age and gender. 91,554 samples were tested. Dengue was confirmed by RT-qPCR, culture or NS1-ELISA in 7097 (7.8%) cases and was IgM ELISA-positive in 19,290 (21.1%) cases. DENV1, DENV2, DENV3, and DENV4 were detected in 2218 (39.5%), 2580 (45.9%), 591 (10.5%), and 230 (4.1%) cases. DENV1 and DENV2 were the predominant serotypes, but all serotypes caused epidemics. The largest outbreak occurred in 2010 with 1080 DENV2 cases reported. The incidence was higher among adults during epidemic years, with significant increases in 2005, 2007, and 2013 DENV1 outbreaks, the 2010 DENV2 and 2003 DENV3 outbreaks. Adults had a lower incidence immediately after epidemics, which is likely linked to increased immunity.

show abstract

Section: Plos Neglected Tropical Diseasesmentioning

confidence: 99%

Epidemiology of dengue fever in Guatemala

Signor¹,

Edwards²,

Escobar³

et al. 2020

PLoS Negl Trop Dis

View full text Add to dashboard Cite

show abstract

“…And, Brazil spent 20.82 million dollars PPP indirect cost of prevention and control of Aedes aegypti. France, a developed-country, spent 15 million dollars PPP on direct medical-cost of hospitalization [23].…”

Section: Fig 2 Common Aedes Aegypti Breeding-site Including In Malmentioning

confidence: 99%

“…Two such study brought the analyses of the intangible-cost, represented by the Quality-Adjusted Life Years (QALY). In Panama, there had been found an average of 67% QALY during the worst days of illness in 2005 and in Malaysia, the average had been 60% QALY in 2009 [23].…”

Section: Fig 2 Common Aedes Aegypti Breeding-site Including In Malmentioning

confidence: 99%

See 1 more Smart Citation

Eliminating Dengue Fever should be Easy Compared to Malaria – In a Malaysian Perspective

Ahmad¹,

Koay²

2020

AJRID

View full text Add to dashboard Cite

Introduction: In 1993, the International Task Force for Disease Eradication thought over and concluded that only six diseases are eradicable – but, malaria, dengue fever (and, dengue hemorrhagic fever) were not included. In 2010, 99 countries reported 219 million cases of malaria and 660,000 deaths. In Malaysia in 2011, 5152 cases had been reported causing not more than 30 deaths. Over 2.5 billion are at risk of dengue fever given the endemicity in excess of 100 countries, compared to nine countries in 1970. The WHO estimate 50-100 million cases annually globally, with approximately 500,000 dengue haemorrhagic fever, and an estimated 22,000 death each year. In Malaysia in 2017, there is found 83,849 reported cases of dengue fever with 177 deaths. There is a compelling need to give thought here to an elimination/eradication programme on dengue fever in Malaysia, realizing there is presently a malaria-elimination programme already. Aim: The Aim of this Review is to contemplate on the priority of possible public-health intervention of infectious-diseases, the International Task Force on Disease Eradication, and the three principle/indicators toward successful eradication/elimination programme, and the cost, beside describing the epidemiology and eradication/elimination of malaria in Malaysia, including the human and economic cost of malaria, in a comparison with dengue fever, including the dengue control & prevention programme and the potential in the innovative-methods, and why a dengue fever elimination programme is timely and imperative. Methodology: This article is a Narrative Review, and the author focus the article around three articles published by the author in recent times on dengue fever, and two on malaria. Additionally, the author contemplate around relevant newer article by various author retrieved through PubMed and Google Search. Results: Based on priority of possible public-health intervention of infectious-diseases by the International Task Force on Disease Eradication, and the principle/indicator(s) identified by the Task Force, and the Dahlem Conference, toward successful eradication/elimination programme, and the World Health Assembly on dengue fever, it is felt that a dengue fever elimination programme is timely and imperative, beside found very cost-beneficial. Conclusion: Mankind can eliminate dengue fever, even if not actually eradicating the disease, in a very much feasible and cost-beneficial programme, beginning in every nation and every region of the world, prior to grouping to become a global-programme.

show abstract

“…Evidence from economic burden of disease studies in both economically developed and developing countries continue to be used to advocate for increased investments in health development [19][20][21][22][23][24][25][26][27][28][29][30][31][32].…”

Section: Introductionmentioning

confidence: 99%

Monetary value of disability-adjusted-life-years lost from all causes in Mauritius

Musango¹,

Nundoochan

Wilder

et al. 2019

Preprint

View full text Add to dashboard Cite

Background The Republic of Mauritius lost a total of 402,565 disability-adjusted-life-years (DALY) from all causes in 2017. The objectives of this study were (a) to estimate the monetary value of DALY lost in 2017, and projected to be lost from all causes in Mauritius in 2030; and (b) to estimate the monetary value of DALY savings in year 2030, if the country would attain the United Nations Sustainable Development Goal 3 (SDG3) targets 3.1, 3.2, 3.3, 3.4 and 3.6.Methods Human capital approach is used to monetarily value DALY lost from 293 causes in 2017. The monetary value of DALY lost in 2017 from each cause is equal to the Mauritius net gross domestic product (GDP) per capita multiplied by the number of DALY lost from a specific cause. The percentage reductions implied in the five SDG3 targets were used in the projections of the monetary values of DALY expected in 2030. The potential savings equals monetary value of DALY lost in 2017 minus monetary value of DALY expected in 2030. The DALY data was obtained from the Institute of Health Metrics and Evaluation Global Burden of Disease Study 2017 database; the current health expenditure per capita data was from the WHO Global Health Expenditure Database; and the per capita GDP data was obtained from the IMF outlook database.Results The DALY lost in 2017 had a total monetary value of Int$9,564,741,771. Of which, 82.9% resulted from non-communicable diseases; 10.2% from communicable, maternal, neonatal and nutritional diseases; and 6.9% from injuries. Full attainment of the five SDG 3 targets would avert DALY losses with a value of Int$2,986,241,156.Conclusions Diseases and injuries causes a significant DALY lost per year with a substantive monetary value. Full achievement of the SDG3 targets 3.1, 3.2, 3.3, 3.4 and 3.6 might potentially save the country about 9.351% of the total GDP of Mauritius in 2019. In order to achieve such savings, the country require to further strengthen the national health system, the other systems that tackle social determinants of health, and the national health research system.

show abstract

Cost of illness and program of dengue: A systematic review

Cited by 37 publications

References 44 publications

Epidemiology of dengue fever in Guatemala

Epidemiology of dengue fever in Guatemala

Eliminating Dengue Fever should be Easy Compared to Malaria – In a Malaysian Perspective

Monetary value of disability-adjusted-life-years lost from all causes in Mauritius

Contact Info

Product

Resources

About